NEUCHÂTEL, Svizzera–(BUSINESS WIRE)–Se voi, o qualcuno che conoscete, sta affrontando un intervento alla cataratta, orientarsi nel massiccio volume delle informazioni può risultare difficile. Non è sempre facile reperire dati affidabili, ed è proprio…
Author: Business Wire
Swiss Virtual Clinic，專為白內障手術打造的線上平台
瑞士，紐沙提勒–(BUSINESS WIRE)–(美國商業資訊)– 如果您本人或是親朋好友要進行白內障手術，一定會發現，光是排山倒海而來的大量資訊便足以讓人喘不過氣。想找出值得信賴的詳細資料並不容易，正因為如此，Swiss Advanced Vision (SAV-IOL SA) 特別打造了「Swiss Virtual Clinic」。這座首開先河的線上平台專為患者及眼科專業人員量身打造，以一站式服務提供正確資訊，告別過去種種繁瑣惱人的工作。 白內障手術是一種常見的眼科手術，然而許多患者對它仍…
专为白内障手术量身设计的瑞士虚拟诊所
瑞士新特尔–(BUSINESS WIRE)–(美国商业资讯)– 如果您或您认识的人正在考虑白内障手术，分析海量的信息可能会让人感到不知所措。可靠的细节并不总是容易找到，而这正是SAV-IOL SA创建瑞士虚拟诊所（Swiss Virtual Clinic）的原因。这一首创的在线平台为患者和眼科护理专业人员提供了定制化的访问服务，让用户以前所未有的简单方式获取正确信息。 白内障手术是最常见的眼科手术之一，但对许多患者来说，它仍然充满疑问。瑞士虚拟诊所通过易于使用的界面让一切变得更加清晰，该界面解…
Swiss Virtual Clinic criada exclusivamente para cirurgia de catarata
NEUCHÂTEL, Suíça–(BUSINESS WIRE)–Se você ou alguém que você conhece está passando por cirurgia de catarata, classificar o grande volume de informações pode ser estressante. Detalhes confiáveis nem sempre são fáceis de encontrar, e é exatamente por is…
Swiss Virtual Clinic uniquely designed for Cataract Surgery
NEUCHÂTEL, Switzerland–(BUSINESS WIRE)–Swiss Virtual Clinic simplifies cataract surgery for patients & professionals. Join now at sav-iol.com or visit SAV-IOL at APAO Congress (April 3-6)!
GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics confirme que les résultats financiers consolidés définitifs de l'exercice 2024 sont conformes aux estimations
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les …
Samenvatting: Ravenna wordt de eerste kleurenblindvriendelijke stad in Italië: evenement en donatie van nieuwe EnChroma-brillen
RAVENNA, Italië–(BUSINESS WIRE)–Morgen op 19 maart 2025, om 16:30 uur, wordt de conferentie ‘How Colourblind People See’ gehouden in de Martini Hall van MAR – het Museum of Ar t van Ravenna. Dit evenement is bedoeld om het bewustzijn over kleurenblin…
Ravenne devient la première ville italienne amie du daltonisme et organise un événement ainsi qu’un nouveau don de nouvelles lunettes EnChroma
RAVENNE, Italie–(BUSINESS WIRE)–Demain, 19 mars 2025, à 16 h 30, la conférence « Comment voient les daltoniens » se tiendra dans le Hall Martini du MAR – le Musée d’art de Ravenne . Cet événement vise à sensibiliser au daltonisme et aux défis que peu…
Resumen: Rávena se convierte en la primera ciudad italiana en acoger a los daltónicos: evento y donación de las nuevas gafas EnChroma
RAVENNA, Italia–(BUSINESS WIRE)–Mañana, 19 de marzo de 2025, a las 16:30 horas, tendrá lugar la conferencia «How Colourblind People See» en la sala Martini del MAR – Museo de Arte de Rávena . Este acto está dedicado a concienciar sobre el daltonismo …
Ravenna wird zur ersten farbenblindenfreundlichen Stadt Italiens: Veranstaltung und neue EnChroma-Brillenspende
RAVENNA, Italien–(BUSINESS WIRE)–Morgen, am 19. März 2025, um 16:30 Uhr, findet in der Martini-Halle des MAR – Ravennas Museum of Ar t die Konferenz „Wie farbenblinde Menschen sehen“ statt. Diese Veranstaltung soll das Bewusstsein für Farbenblindheit…
Ravenna prima città accessibile ai daltonici: un evento e una nuova donazione di occhiali EnChroma
Ravenna, Italia–(BUSINESS WIRE)–Domani, 19 marzo 2025, alle ore 16:30 presso la Sala Martini del MAR – Museo d’Arte della città di Ravenna, si terrà la conferenza “Come vedono i daltonici”, un evento dedicato alla comprensione del daltonismo e delle …
Ravenna Becomes the First Colourblind-Friendly City in Italy: Event and New EnChroma Glasses Donation
RAVENNA, Italy–(BUSINESS WIRE)–Tomorrow, March 19, 2025, at 4:30 PM, the conference “How Colourblind People See” will be held at the Martini Hall of MAR – Ravenna’s Museum of Art. This event is dedicated to raising awareness about colour blindness an…
Aurion Biotech Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
SEATTLE & CAMBRIDGE, Mass & TOKYO–(BUSINESS WIRE)–Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that the Company is proud to have been name…
STAAR Surgical Announces Realignment of Leadership Structure
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the following changes to right size and …
OSRX Expands Ophthalmic Solutions with New Medications and Post-Op Kits to Patients’ Doors
MISSOULA, Mont.–(BUSINESS WIRE)–OSRX expands ophthalmic care with new meds & direct-to-patient post-op kits, enhancing workflows & patient access.
National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the “Board”),…
National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the “Board”),…
Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced unaudited preliminary financial results for the fourth quarter and year ended December 31, 2024, as well as rev…
Harrow Launches VEVYE® Access for All
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today introduced VEVYE® Access for All, a groundbreaking initiative that underscores Harrow’s long‑standing commitment to acces…